High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success

2015 ◽  
Vol 115 (1) ◽  
pp. 84-89 ◽  
Author(s):  
Joelle Helou ◽  
Laura D’Alimonte ◽  
Andrew Loblaw ◽  
Hans Chung ◽  
Patrick Cheung ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Dose Rate ◽  
High Dose Rate ◽  
High Dose ◽  
Intermediate Risk ◽  
Predictors Of Success ◽  
Long Term Outcomes ◽  
Risk Prostate Cancer ◽  
Brachytherapy Boost

Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years

2016 ◽  
Vol 120 (1) ◽  
pp. 56-60 ◽  
Author(s):  
John W. Yaxley ◽  
Kevin Lah ◽  
Julian P. Yaxley ◽  
Robert A. Gardiner ◽  
Hema Samaratunga ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
Dose Rate ◽  
High Dose Rate ◽  
High Dose ◽  
Long Term Outcomes ◽  
High Risk Prostate Cancer ◽  
Risk Prostate Cancer

A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer

Brachytherapy ◽  
2013 ◽  
Vol 12 (5) ◽  
pp. 428-433 ◽  
Author(s):  
Daniel E. Spratt ◽  
Lawrence M. Scala ◽  
Michael Folkert ◽  
Laszlo Voros ◽  
Gil’ad N. Cohen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Dose Rate ◽  
Stereotactic Body Radiotherapy ◽  
High Dose Rate ◽  
High Dose ◽  
Intermediate Risk ◽  
Risk Prostate Cancer ◽  
Dosimetric Analysis
Sign in / Sign up

Export Citation Format

Share Document